• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 19, 2009

View Archived Issues

AEterna Zentaris presents update on phase III study 041 of cetrorelix pamoate in BPH

Read More

Natalizumab improves quality of life in Crohn's disease patients

Read More

SP-304 well tolerated in phase I study in healthy volunteers

Read More

Long-term safety and low-dose efficacy of ropinirole PR studied in Parkinson's disease

Read More

Boehringer Ingelheim claims HIV integrase inhibitors for the treatment of HIV infection

Read More

Boehringer Ingelheim claims the discovery of novel antimigraine compounds

Read More

Long-term and other data on adalimumab in Crohn's disease analyzed

Read More

Xanodyne receives FDA approval for Zipsor

Read More

CuraGen advances to second stage of enrollment in phase I/II trial of CR011-vcMMAE

Read More

MacroGenics and Lilly complete enrollment in phase II/III trial of teplizumab in diabetes

Read More

Virax enrolls 50% of participants into South African phase I/IIa trial of VIR-201 HIV vaccine

Read More

TGen reports positive results from study of genetic markers in diabetes

Read More

Novartis presents novel farnesyl pyrophosphate synthase inhibitors for osteoporosis

Read More

FDA Arthritis Advisory Committee sets date to review Auxilium's BLA for Xiaflex

Read More

Retreatment with TRU-015 improves rheumatoid arthritis disease activity in phase IIb trial

Read More

Paladin launches Twinject Twinpack in Canada for anaphylaxis

Read More

Anti-IL-17A antibody AIN-457 induces clinical responses in rheumatoid arthritis patients

Read More

Celgene's Revlimid recommended for relapsed/refractory multiple myeloma in the U.K.

Read More

Debiopharm and Moffitt Cancer Center sign agreement for Debio-0928

Read More

SGN-35 begins phase II trial for anaplastic large cell lymphoma

Read More

Clinical hold removed from IMPACT-DCM trial of cardiac repair cells

Read More

First European launch for new Blopress Plus strengths

Read More

Anti-GM-CSF antibody MT-203 begins first phase I study

Read More

Second phase II study for HP-802-247 cell-based wound therapy

Read More

Novel angiotensin receptor blocker K-868 active against experimental diabetic nephropathy

Read More

OSI Prosidion reports development of dual DPP-IV inhibitor/GPR119 agonist

Read More

Meal-related symptoms improved with Z-338 in functional dyspepsia patients

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 25, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 24, 2025.
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 24, 2025
  • HHS Secretary Robert Kennedy

    HHS budget hearing mashup of the worst and the best

    BioWorld
    “I expressed deep concerns with your nomination, Secretary Kennedy, and somehow, unfortunately, you have exceeded my expectations in the worst possible ways,”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe